Prelude Capital Management’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-100
Closed -$1K 2102
2019
Q3
$1K Sell
100
-3,493
-97% -$42.6K ﹤0.01% 1640
2019
Q2
$47K Sell
3,593
-1,710
-32% -$20.3K ﹤0.01% 1127
2019
Q1
$76K Sell
5,303
-3,919
-42% -$56.9K ﹤0.01% 1011
2018
Q4
$122K Buy
9,222
+8,222
+822% +$98.4K 0.01% 869
2018
Q3
$11K Buy
+1,000
New +$10.7K ﹤0.01% 1435
2017
Q1
Sell
-10,700
Closed -$87K 1639
2016
Q4
$87K Buy
10,700
+4,453
+71% +$38.1K 0.01% 875
2016
Q3
$59K Buy
6,247
+4,253
+213% +$55.3K 0.01% 994
2016
Q2
$27K Buy
+1,994
New +$22.6K ﹤0.01% 1188
2014
Q3
Sell
-443
Closed -$4K 1997
2014
Q2
$4K Buy
+443
New +$4.21K ﹤0.01% 1849
2013
Q4
Sell
-2,100
Closed -$35K 1772
2013
Q3
$35K Buy
+2,100
New +$36.3K 0.01% 1046

Other funds holding LFVN

Prelude Capital Management's LFVN Position: Q4 2019 in Review

Prelude Capital Management sold out of LifeVantage (LFVN) in Q4 2019, closing a stake of 100 shares — an estimated $1K sold.

Prelude Capital Management first reported a position in LFVN in Q3 2013 and held it in 10 quarters. The position peaked at $122K in Q4 2018. 86 funds tracked by Wall St. Rank hold LFVN as of Q4 2019.

  • Prelude Capital Management reported no remaining LifeVantage position as of Q4 2019 after selling out during the quarter.
  • Prelude Capital Management sold 100 LifeVantage shares in Q4 2019, an estimated $1K.
  • Prelude Capital Management first reported a position in LifeVantage in Q3 2013 and held it in 10 quarters.
  • Prelude Capital Management's LifeVantage position peaked at $122K in Q4 2018.
  • 86 funds tracked by Wall St. Rank held LifeVantage as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.